Chubb Ltd’s GSK GSK Stock Holding History

Chubb Ltd’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-320,000	Closed	-$16.7M	–	5
2019 Q1	$16.7M	Hold	320,000	–	–	11.22%	5
2018 Q4	$15.3M	Hold	320,000	–	–	11.08%	5
2018 Q3	$16.1M	Hold	320,000	–	–	10.65%	6
2018 Q2	$16.1M	Hold	320,000	–	–	6.78%	9
2018 Q1	$15.6M	Hold	320,000	–	–	6.8%	9
2017 Q4	$14.2M	Hold	320,000	–	–	6.18%	10
2017 Q3	$16.2M	Hold	320,000	–	–	7.08%	7
2017 Q2	$17.2M	Hold	320,000	–	–	7.33%	6
2017 Q1	$16.9M	Hold	320,000	–	–	7.28%	6
2016 Q4	$15.4M	Hold	320,000	–	–	6.76%	6
2016 Q3	$17.3M	Hold	320,000	–	–	7.82%	3
2016 Q2	$17.3M	Hold	320,000	–	–	7.49%	3
2016 Q1	$16.2M	Buy	+320,000	New	+$15.9M	4.42%	6

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Chubb Ltd's GSK Position: Q2 2019 in Review

Chubb Ltd sold out of GSK (GSK) in Q2 2019, closing a stake of 320,000 shares — an estimated $16.7M sold.

Chubb Ltd first reported a position in GSK in Q1 2016 and held it in 13 quarters. The position peaked at $17.3M in Q2 2016. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Chubb Ltd reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Chubb Ltd sold 320,000 GSK shares in Q2 2019, an estimated $16.7M.
Chubb Ltd first reported a position in GSK in Q1 2016 and held it in 13 quarters.
Chubb Ltd's GSK position peaked at $17.3M in Q2 2016.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Chubb Ltd's 13F filing for Q2 2019, filed 7 Aug 2019.